Primer extension preamplification (PEP) was first described as a method for whole genome amplification, starting from a single cell, originally a spermatozoon, in order to perform genetic recombination studies. Its usefulness for preimplantation diagnosis was shown soon after; the only drawback was the length of the procedure (>14 h). We have developed a shorter PEP protocol for single human blastomeres, enabling us to examine several genetic loci of interest in human genetic diseases with a good amplification efficiency.
Introduction
first described a method for whole genome amplification which they called primer extension preamplification (PEP), starting from a single cell. The method involved amplifying the whole genome using random pentadecanucleotides (15-mers), after which sequences of interest (12 in this case) were amplified using nested polymerase chain reaction (PCR) (Monk and Holding, 1990) . They proposed that their method might be used for single gamete typing (genetic recombination studies), preimplantation genetic diagnosis and analysis of small DNA samples, such as forensic samples or ancient DNA. When used for preimplantation diagnosis, PEP could be useful for typing two mutations in one gene that cannot be amplified simultaneously, for checking doubtful results or, in recessive sex-linked disorders, for determining the exact genotype as well as the gender of the embryo. Soon after this, a first attempt was made at shortening the PEP protocol for use in preimplantation diagnosis (Xu et al., 1993) . There is only 12 h between the biopsy of the embryos at the beginning of day three after insemination and the transfer of the unaffected embryos, if the whole procedure is to be carried out in 1 working day. A protocol as first described with a length of >14 h, not including the time necessary for biopsy and diagnostic analysis, is too long. Unfortunately, the shorter protocol described by Xu et al. (1993) was not very successful as regards amplification efficiencies. A third group (Kristjansson et al, 1994; Snabes et al., 1994) obtained good results in amplifying several exons of the Duchenne muscular dystrophy gene, exons 11 and 12 of the Tay-Sachs gene, the cystic fibrosis (AF508) locus, intron 18 of the factor VIII gene and ZFX and ZFY sequences, using however the long protocol first described by Zhang et al. (1992) . Our aim was to reduce the length of the PEP procedure, while retaining sufficient efficiency in amplifying different sequences in single human blastomeres, to be able to consider the use of PEP in selected cases of preimplantation diagnosis.
Sampling of blastomeres
As a source of blastomeres, we used embryos from our intracytoplasmic sperm injection (ICSI) programme which were unsuitable for transfer or cryopreservation because of fragmentation and irregular blastomeres. Agreement was obtained from the donating patients and the institutional Ethical Committee. The zona pellucida was first removed using acidic Tyrode's solution. The embryos were then placed in a Ca 2+ and Mg 2+ -free M2 medium, containing 1.25 mg/ ml trypsin. The dissociated blastomeres were checked for the presence of a nucleus under the dissection microscope (X50 magnification), washed three times in the same medium without trypsin and, finally, each individual blastomere was transferred to a 0.2 ml PCR tube (Perkin Elmer, Brussels, Belgium) containing 5 u.1 alkaline lysis buffer [200 mM KOH, 50 mM dithiothreitol (DTT)]. For each blastomere, an aliquot of the last washing droplet was added to a separate PCR tube to serve as a blank. The blastomeres were kept at -80°C until further processing.
Lysis of the blastomeres
The blastomeres were heated at 65°C for 10 min (Cui et al., 1989) , and then cooled to 4°C. The alkaline lysis buffer was neutralized with 5 |il neutralization buffer (900 mM Tris-HCl pH 8.3, 300 mM KC1 and 200 mM HC1).
PEP procedure
The reaction mixture was that used by Zhang et al. (1992) , with final concentrations of 10 mM Tris-HCl, pH 8.3, 50 mM KCI, 2.5 mM MgCI 2 , 100 uM of each dNTP, and 35 uM of 15-base random primers (Operon Technologies, Alameda, CA, USA) in a total volume of 60 u.1. Several programmes of different lengths were compared, all run on a GeneAmp System 9600 (Perkin Elmer). They are described in Table I . For the longest PEP programme, numbered I in Table I and which was the one originally described (Zhang et al., 1992) , 28 single blastomeres were used. For each of the shorter programmes, 15 blastomeres were examined (numbered 2, 3 and 4 in Table I ).
PCR procedures
Four different sequences were amplified following PEP: exon 5 of the steroid sulphatase gene (STS) on the X-chromosome (Liu et al., K.Sermon of al. 1994), exon 10 of the cystic fibrosis gene (Liu et al., 1992) , surrounding the AF508 mutation, exon 11 of the a-chain of ^-Nacetylhexosaminidase, around the TATC-insertion site causing TaySachs disease (Sermon et al., 1995a ) (short TS) and exon 11 and 12 of the same gene, containing the two most frequent mutation sites (the TATC insertion in exon 11 and a splice site mutation at the 5' end of intron 12, where a G is converted to a C) in Tay-Sachs disease (long TS) (Sermon et al., 1995b) . Each time, a nested PCR strategy was used; the protocols are described in detail for the DNA Thermal Cycler in the publications mentioned and were adapted to suit the GeneAmp System 9600 according to the manufacturer's instructions (Table II) . For the STS sequence, the first PCR yields a fragment of 180 bp and the second PCR a 112 bp fragment. The first PCR fragment of the CF sequence is 491 bp long, while the second PCR fragment is 98 bp long. The short-TS PCR amplifies a 179 bp fragment in the first PCR and a 123 bp fragment in the second PCR. The first PCR of the long TS yields a fragment of 525 bp, while the second PCR yields a 135 bp fragment of the exon/intron 12 of the Tay-Sachs gene. Three, 6, or 10 u.1 were taken from the PEP mixture as a template for the first PCR, while 3 u.1 were taken from the first PCR as a template for the second PCR. The amplification efficiencies were checked on a 2% agarose gel; since we did not expect any of the tested blastomeres to be carriers of (or affected by) cystic fibrosis or Tay-Sachs disease, no mutation analysis was performed.
Statistical analysis
The data were compared using the % 2 test calculated with Microsoft ExceJl 5 on a Macintosh Performa 5200 computer.
Results
We compared four PEP programmes of diminishing length, the longest of which was that described by Zhang et al. (1992) . The amplification efficiencies obtained with these programmes, using 3 (il of the PEP product, are described in Table III . The shortest programme, taking 5 h, had PCR efficiencies which were significantly lower using a x 2 test [35 out of 60 (58%) amplified] than the other three programmes. The latter had overall efficiencies which were not significantly different. The amplification efficiencies also differed according to the sequences analysed. The STS sequence gave the best result: with only 3 |il from the PEP mixture, a maximal efficiency of 93% was reached (Table III) . The second most satisfactory results were obtained with the CF sequence, while the TS sequences gave the least satisfactory results, of which the worst were from the long TS sequence. To improve the efficiency of each programme, we increased the volume of PEP mixture used as template to 6 and 10 (il. Since our aim was to shorten the PEP procedure and since programme 4 gave results below average, we did not check the amplification efficiency using 6 and 10 |il from the PEP programmes 1 (the longest programme) or 4.
These results are described in Table IV : the sequence with the lowest efficiency (long TS) showed the best improvement with 6 Hi (83%) and 10 Lil (90%). The CF sequence showed no improvement with 6 |il (total 73%), but gave better results with 10 Hi (total 90%). The short TS showed an intermediate improvement from 73% with 3 (il to 80% with 6 |il of the samples amplified. Since we had insufficient PEP mixture, we did not test the efficiency for the STS sequence with 6 and 10 (il as template or for the short TS sequence with 10 (il as template. In programme 2, when the results of the different sequences were pooled together, there was a significant difference (P < 0.01) between 3-10 (il. This difference was not present when using programme 3. Also, although programme Single blastomere analysis using short PEP protocols 2 performed slightly better than programme 3, there was no statistically significant difference between these programmes.
Discussion
Here we describe a PEP programme of 5 h 30 min (programme 2 in Table I ), giving good amplification efficiencies when nested PCRs for different sequences are performed after the PEP. One factor affecting these efficiencies is the length of the first PCR product, although this factor cannot explain all the differences in efficiency. When performing the nested PCRs on single blastomeres, the STS and CF sequences give similar results (>95% amplification efficiency) while, following PEP, STS gives better results than CF, and short TS gives better results than long TS. However, when performing these PCRs directly on single cells, the number of cells showing a signal is similar at -90%. The amplification efficiencies obtained with our programme compare well with those of other published results; 83-100% (on sperm cells), Zhang et al. (1992) ; 93% (on amniocytes, chorionic villus cells and blastomeres), Kristjansson et al. (1994) ; and 93% (lymphoblasts and blastomeres), Snabes etal. (1994) who used the longer procedure. Xu et al. (1993) described three shorter PEP programmes used on blastomeres, but with much lower efficiencies: 80, 30 and 72% for the amelogenin gene sequence on the X-chromosome and 78, 39 and 47% for exon 10 of the CF gene; we achieved 93% efficiency for the STS sequence and 73-100% for the CF sequence. Moreover, we showed that by using up to 10 ^1 of the PEP mixture, efficiency did not decline, as was originally thought (Kristjansson et al, 1994) , but rose, as was shown dramatically for the long TS sequence. However, we are aware that this does not apply to all sequences, and that the ideal experimental conditions have to be determined for every PCR. These will probably differ from laboratory to laboratory and even from one period of experimentation to another.
Using our PEP programme and PCRs adapted for the GeneAmp System 9600, we would be able to complete a whole preimplantation diagnosis procedure in under 12 h (blastomere biopsy, 5 h 30 min for the PEP, 2 h 30 min to 3 h for two nested PCRs, and mutation analysis), which leads us to consider this method for selected cases. These could include analysis of possibly compound heterozygote embryos and gender determination in embryos at risk of a recessive sexlinked disorder, where a specific mutation analysis would be performed concurrently.
